Literature DB >> 14640526

New bromotyrosine derivatives from an association of two sponges, Jaspis wondoensis and Poecillastra wondoensis.

Yujin Park1, Yonghong Liu, Jongki Hong, Chong-O Lee, Heeyeong Cho, Dong-Kyoo Kim, Kwang Sik Im, Jee H Jung.   

Abstract

Three new bromotyrosine derivatives (4-6) were isolated from an association of two sponges, Jaspis wondoensis and Poecillastra wondoensis, along with the previously described (E,E)-psammaplin A (1), (E,Z)-psammaplin A (2), psammaplin D (3), bisaprasin (7), and (3-bromo-4-hydroxyphenyl)acetonitrile (8). The structures of the new compounds were established on the basis of NMR and MS spectroscopic analysis. The compounds 1, 3, and 5-7 displayed significant cytotoxicity against human lung (A549), ovarian (SK-OV-3), skin (SK-MEL-2), CNS (XF498), and colon (HCT15) cancer cell lines. Compounds 3-7 were further evaluated for antibacterial activity against methicillin- or ofloxacin-resistant Staphylococcus strains. Compound 4 exhibited more potent antibacterial activity than meropenem against several strains.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14640526     DOI： 10.1021/np030162j

Source DB:  PubMed          Journal:  J Nat Prod        ISSN： 0163-3864            Impact factor:   4.050


  11 in total

Review 1.  The marine bromotyrosine derivatives.

Authors:  Jiangnan Peng; Jing Li; Mark T Hamann
Journal:  Alkaloids Chem Biol       Date:  2005

2.  Induction of apoptosis in endometrial cancer cells by psammaplysene A involves FOXO1.

Authors:  Emily Berry; Jennifer L Hardt; Jon Clardy; John R Lurain; J Julie Kim
Journal:  Gynecol Oncol       Date:  2008-11-28       Impact factor: 5.482

3.  Psammaplin A as a general activator of cell-based signaling assays via HDAC inhibition and studies on some bromotyrosine derivatives.

Authors:  Malcolm W B McCulloch; Gary S Coombs; Nikhil Banerjee; Tim S Bugni; Kendell M Cannon; Mary Kay Harper; Charles A Veltri; David M Virshup; Chris M Ireland
Journal:  Bioorg Med Chem       Date:  2008-11-05       Impact factor: 3.641

4.  Biochemical and Anti-Triple Negative Metastatic Breast Tumor Cell Properties of Psammaplins.

Authors:  Yu-Dong Zhou; Jun Li; Lin Du; Fakhri Mahdi; Thuy P Le; Wei-Lun Chen; Steven M Swanson; Kounosuke Watabe; Dale G Nagle
Journal:  Mar Drugs       Date:  2018-11-10       Impact factor: 5.118

Review 5.  Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects.

Authors:  Brigitte Bauvois; Daniel Dauzonne
Journal:  Med Res Rev       Date:  2006-01       Impact factor: 12.944

6.  Ochraceopetalin, a Mixed-Biogenetic Salt of Polyketide and Amino Acid Origins from a Marine-Derived Aspergillus ochraceopetaliformis Fungus.

Authors:  Sung Chul Park; Jung-Ho Lee; Ji-Yeon Hwang; Oh-Seok Kwon; Lijuan Liao; Dong-Chan Oh; Ki-Bong Oh; Jongheon Shin
Journal:  Mar Drugs       Date:  2021-07-26       Impact factor: 5.118

7.  Two new jaspamide derivatives from the marine sponge Jaspis splendens.

Authors:  Sherif S Ebada; Victor Wray; Nicole J de Voogd; Zhiwei Deng; Wenhan Lin; Peter Proksch
Journal:  Mar Drugs       Date:  2009-09-15       Impact factor: 5.118

8.  Antiplasmodial activities of homogentisic acid derivative protein kinase inhibitors isolated from a Vanuatu marine sponge Pseudoceratina sp.

Authors:  Nicolas Lebouvier; Valérie Jullian; Isabelle Desvignes; Séverine Maurel; Arnaud Parenty; Dominique Dorin-Semblat; Christian Doerig; Michel Sauvain; Dominique Laurent
Journal:  Mar Drugs       Date:  2009-11-23       Impact factor: 5.118

9.  Cytotoxicity of psammaplin A from a two-sponge association may correlate with the inhibition of DNA replication.

Authors:  Yahong Jiang; Eun-Young Ahn; Seung Hee Ryu; Dong-Kyoo Kim; Jang-Su Park; Hyun Joo Yoon; Song You; Burm-Jong Lee; Dong Seok Lee; Jee H Jung
Journal:  BMC Cancer       Date:  2004-09-30       Impact factor: 4.430

Review 10.  Marine-Derived Secondary Metabolites as Promising Epigenetic Bio-Compounds for Anticancer Therapy.

Authors:  Mariarosaria Conte; Elisabetta Fontana; Angela Nebbioso; Lucia Altucci
Journal:  Mar Drugs       Date:  2020-12-31       Impact factor: 5.118
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.